These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

481 related items for PubMed ID: 20621872

  • 1. Nonadherence to angiotensin-converting enzyme inhibitors and/or angiotensin II receptor blockers among high-risk patients with diabetes in Medicare Part D programs.
    Yang Y, Thumula V, Pace PF, Banahan BF, Wilkin NE, Lobb WB.
    J Am Pharm Assoc (2003); 2010; 50(4):527-31. PubMed ID: 20621872
    [Abstract] [Full Text] [Related]

  • 2. Predictors of medication nonadherence among patients with diabetes in Medicare Part D programs: a retrospective cohort study.
    Yang Y, Thumula V, Pace PF, Banahan BF, Wilkin NE, Lobb WB.
    Clin Ther; 2009 Oct; 31(10):2178-88; discussion 2150-1. PubMed ID: 19922889
    [Abstract] [Full Text] [Related]

  • 3. A Pharmacist Telephone Intervention to Identify Adherence Barriers and Improve Adherence Among Nonadherent Patients with Comorbid Hypertension and Diabetes in a Medicare Advantage Plan.
    Abughosh SM, Wang X, Serna O, Henges C, Masilamani S, Essien EJ, Chung N, Fleming M.
    J Manag Care Spec Pharm; 2016 Jan; 22(1):63-73. PubMed ID: 27015053
    [Abstract] [Full Text] [Related]

  • 4. Effects of a step-therapy program for angiotensin receptor blockers on antihypertensive medication utilization patterns and cost of drug therapy.
    Yokoyama K, Yang W, Preblick R, Frech-Tamas F.
    J Manag Care Pharm; 2007 Apr; 13(3):235-44. PubMed ID: 17407390
    [Abstract] [Full Text] [Related]

  • 5. High-risk diabetic patients in Medicare Part D programs: are they getting the recommended ACEI/ARB therapy?
    Yang Y, Thumula V, Pace PF, Banahan BF, Wilkin NE, Lobb WB.
    J Gen Intern Med; 2010 Apr; 25(4):298-304. PubMed ID: 20108127
    [Abstract] [Full Text] [Related]

  • 6. Retrospective claims database analysis to determine relationship between renin-angiotensin system agents, rehospitalization, and health care costs in patients with heart failure or myocardial infarction.
    Sun SX, Ye X, Lee KY, Dupclay L, Plauschinat C.
    Clin Ther; 2008 Apr; 30 Pt 2():2217-27. PubMed ID: 19281916
    [Abstract] [Full Text] [Related]

  • 7. A Motivational Interviewing Intervention to Improve Adherence to ACEIs/ARBs among Nonadherent Older Adults with Comorbid Hypertension and Diabetes.
    Mohan A, Majd Z, Johnson ML, Essien EJ, Barner J, Serna O, Gallardo E, Fleming ML, Ordonez N, Holstad MM, Abughosh SM.
    Drugs Aging; 2023 Apr; 40(4):377-390. PubMed ID: 36847995
    [Abstract] [Full Text] [Related]

  • 8. Adherence Tradeoff to Multiple Preventive Therapies and All-Cause Mortality After Acute Myocardial Infarction.
    Korhonen MJ, Robinson JG, Annis IE, Hickson RP, Bell JS, Hartikainen J, Fang G.
    J Am Coll Cardiol; 2017 Sep 26; 70(13):1543-1554. PubMed ID: 28935030
    [Abstract] [Full Text] [Related]

  • 9. Angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers reduced dementia risk in patients with diabetes mellitus and hypertension.
    Kuan YC, Huang KW, Yen DJ, Hu CJ, Lin CL, Kao CH.
    Int J Cardiol; 2016 Oct 01; 220():462-6. PubMed ID: 27390970
    [Abstract] [Full Text] [Related]

  • 10. Underuse of ACE inhibitors and angiotensin II receptor blockers in elderly patients with diabetes.
    Winkelmayer WC, Fischer MA, Schneeweiss S, Wang PS, Levin R, Avorn J.
    Am J Kidney Dis; 2005 Dec 01; 46(6):1080-7. PubMed ID: 16310574
    [Abstract] [Full Text] [Related]

  • 11. Long-term persistence to mono and combination therapies with angiotensin converting enzymes and angiotensin II receptor blockers in Australia.
    Gadzhanova S, Roughead EE, Bartlett LE.
    Eur J Clin Pharmacol; 2016 Jun 01; 72(6):765-71. PubMed ID: 26961086
    [Abstract] [Full Text] [Related]

  • 12. Accepting Medication Therapy Management Recommendations to Add ACEIs or ARBs in Diabetes Care.
    Hurwitz JT, Grizzle AJ, Augustine J, Rehfeld R, Wild A, Abraham I.
    J Manag Care Spec Pharm; 2016 Jan 01; 22(1):40-8. PubMed ID: 27015050
    [Abstract] [Full Text] [Related]

  • 13. Incidence of and Risk Factors for Severe Adverse Events in Elderly Patients Taking Angiotensin-Converting Enzyme Inhibitors or Angiotensin II Receptor Blockers after an Acute Myocardial Infarction.
    Fang G, Annis IE, Farley JF, Mahendraratnam N, Hickson RP, Stürmer T, Robinson JG.
    Pharmacotherapy; 2018 Jan 01; 38(1):29-41. PubMed ID: 29059475
    [Abstract] [Full Text] [Related]

  • 14. Important treatment gaps in vascular protection for the elderly after type 2 diabetes therapy initiation.
    Guénette L, Breton MC, Hamdi H, Grégoire JP, Moisan J.
    Can J Cardiol; 2013 Dec 01; 29(12):1593-8. PubMed ID: 24183301
    [Abstract] [Full Text] [Related]

  • 15. Study of ACEI versus ARB in managing hypertensive overt diabetic nephropathy: long-term analysis.
    Ozturk S, Sar F, Bengi-Bozkurt O, Kazancioglu R.
    Kidney Blood Press Res; 2009 Dec 01; 32(4):268-75. PubMed ID: 19776644
    [Abstract] [Full Text] [Related]

  • 16. ARBs and ACEis together in the treatment of hypertension and its complications? current practical recommendations.
    Ruilope LM, Segura J.
    Expert Opin Pharmacother; 2010 Nov 01; 11(16):2619-23. PubMed ID: 20977398
    [Abstract] [Full Text] [Related]

  • 17. Comparative effectiveness of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers on major adverse cardiac events in patients with newly diagnosed type 2 diabetes: a nationwide study.
    Shih CJ, Chu H, Ou SM, Chen YT.
    Int J Cardiol; 2015 Nov 15; 199():283-9. PubMed ID: 26218587
    [Abstract] [Full Text] [Related]

  • 18. EVALUATING THE PRESCRIPTION OF ANGIOTENSIN-CONVERTING ENZYME INHIBITORS OR RECEPTOR BLOCKERS IN PATIENTS WITH DIABETES IN JORDAN.
    Mayyas F, Bataineh W, Jarab A.
    Endocr Pract; 2017 Nov 15; 23(11):1289-1296. PubMed ID: 28816537
    [Abstract] [Full Text] [Related]

  • 19. Nonadherence to Statins and Antihypertensives and Hospitalizations Among Elderly Medicare Beneficiaries With Incident Cancer.
    Chopra I, Dwibedi N, Mattes MD, Tan X, Findley P, Sambamoorthi U.
    J Natl Compr Canc Netw; 2017 Nov 15; 15(11):1351-1360. PubMed ID: 29118227
    [Abstract] [Full Text] [Related]

  • 20. Changes in adherence to evidence-based medications in the first year after initial hospitalization for heart failure: observational cohort study from 1994 to 2003.
    Lamb DA, Eurich DT, McAlister FA, Tsuyuki RT, Semchuk WM, Wilson TW, Blackburn DF.
    Circ Cardiovasc Qual Outcomes; 2009 May 15; 2(3):228-35. PubMed ID: 20031842
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.